{"id":7605,"date":"2025-10-15T23:03:29","date_gmt":"2025-10-15T23:03:29","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/10\/15\/gsk-leucovorin-autism-treatment-walmsley\/"},"modified":"2025-10-15T23:03:29","modified_gmt":"2025-10-15T23:03:29","slug":"gsk-leucovorin-autism-treatment-walmsley","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/10\/15\/gsk-leucovorin-autism-treatment-walmsley\/","title":{"rendered":"STAT+: CEO of GSK plays down its role in FDA effort to approve therapy for autism-related condition"},"content":{"rendered":"<p>    STAT+: CEO of GSK plays down its role in FDA effort to approve therapy for autism-related condition<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p>BOSTON \u2014 The CEO of the drugmaker GSK on Wednesday said the company has had a minimal role in the Food and Drug Administration\u2019s effort to update the prescribing information of a long-shelved drug so that it can be used to treat a condition often associated with autism.<\/p>\n<p>The FDA\u2019s request that the company update the prescribing information for its decades-old therapy leucovorin is \u201can administrative request,\u201d the CEO, Emma Walmsley, said during\u00a0a panel discussion at the <a href=\"https:\/\/www.statnews.com\/stat-summit-boston\/\">STAT Summit<\/a>.<\/p>\n<p>\u201cWe have no commercial interest, we have no scientific research, and we\u2019re not pursuing it,\u201d she added. \u201cSo it\u2019s just the administration at this stage.\u201d<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2025\/10\/15\/gsk-leucovorin-autism-treatment-walmsley\/?utm_campaign=rss\">Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Elaine Chen<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2025\/10\/15\/gsk-leucovorin-autism-treatment-walmsley\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>STAT+: CEO of GSK plays down its role in FDA effort to approve therapy for autism-related condition BOSTON \u2014 The CEO of the drugmaker GSK on Wednesday said the company has had a minimal role in the Food and Drug Administration\u2019s effort to update the prescribing information of a long-shelved drug so that it can [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2194,2146,2176,2155,2677,2152],"tags":[2150],"class_list":["post-7605","post","type-post","status-publish","format-standard","hentry","category-biotech","category-fda","category-pharma","category-pharmaceuticals","category-stat-summit","category-stat","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/7605"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=7605"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/7605\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=7605"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=7605"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=7605"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}